Equillium EQ Stock
Equillium Price Chart
Equillium EQ Financial and Trading Overview
| Equillium stock price | 3.11 USD |
| Previous Close | 2.9 USD |
| Open | 2.9 USD |
| Bid | 2.24 USD x 200 |
| Ask | 3.62 USD x 200 |
| Day's Range | 2.8 - 3.12 USD |
| 52 Week Range | 0.27 - 3.12 USD |
| Volume | 4.27M USD |
| Avg. Volume | 468.97K USD |
| Market Cap | 194.74M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.21 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.13 USD |
EQ Valuation Measures
| Enterprise Value | 134.11M USD |
| Trailing P/E | N/A |
| Forward P/E | -11.770551 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.2731137 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.617 |
Trading Information
Equillium Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 683.78% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 3.12 USD |
| 52 Week Low | 0.27 USD |
| 50-Day Moving Average | 2.11 USD |
| 200-Day Moving Average | 1.6 USD |
EQ Share Statistics
| Avg. Volume (3 month) | 468.97K USD |
| Avg. Daily Volume (10-Days) | 603.3K USD |
| Shares Outstanding | 63.23M |
| Float | 31.5M |
| Short Ratio | 9.21 |
| % Held by Insiders | 16.41% |
| % Held by Institutions | 64.22% |
| Shares Short | 2.87M |
| Short % of Float | 5.26% |
| Short % of Shares Outstanding | 4.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.90% |
| Return on Equity (ttm) | -54.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -20267000 USD |
| Net Income Avi to Common (ttm) | -19055000 USD |
| Diluted EPS (ttm) | -0.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 61.32M USD |
| Total Cash Per Share (mrq) | 0.97 USD |
| Total Debt (mrq) | 692K USD |
| Total Debt/Equity (mrq) | 1.16 USD |
| Current Ratio (mrq) | 18.617 |
| Book Value Per Share (mrq) | 0.941 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18878000 USD |
| Levered Free Cash Flow (ttm) | -12542750 USD |
Profile of Equillium
| Country | United States |
| State | CA |
| City | La Jolla |
| Address | 2223 Avenida De La Playa |
| ZIP | 92037 |
| Phone | 858 240 1200 |
| Website | https://www.equilliumbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Q&A For Equillium Stock
What is a current EQ stock price?
Equillium EQ stock price today per share is 3.11 USD.
How to purchase Equillium stock?
You can buy EQ shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Equillium?
The stock symbol or ticker of Equillium is EQ.
Which industry does the Equillium company belong to?
The Equillium industry is Biotechnology.
How many shares does Equillium have in circulation?
The max supply of Equillium shares is 63.23M.
What is Equillium Price to Earnings Ratio (PE Ratio)?
Equillium PE Ratio is now.
What was Equillium earnings per share over the trailing 12 months (TTM)?
Equillium EPS is -0.21 USD over the trailing 12 months.
Which sector does the Equillium company belong to?
The Equillium sector is Healthcare.
Equillium EQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}